Long-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr)

Hormone Research

Volumn 51, Issue 1, 1999, Pages 43-46

  Lavard, L ^b   Sehested, A ^c   Jacobsen, B Brock ^c   Muller, J ^c   Perrild, H ^c   Feldt Rasmussen, U ^a   Parma, J ^c   Vassart, G ^c  

^a Rigshospitalet   (Denmark)

^b AMAGER HOSPITAL   (Denmark)

^c NONE

Author keywords

Germline; Juvenile thyrotoxicosis; Long term follow up; TSH R mutation

Indexed keywords

ANTITHYROID AGENT; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROTROPIN; THYROTROPIN RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BONE AGE; CASE REPORT; CHILD; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EXOPHTHALMOS; FAILURE TO THRIVE; FOLLOW UP; GENE MUTATION; GOITER; HUMAN; INFANT; MALE; NEWBORN; ORBIT; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; THYROTOXICOSIS; TOXIC GOITER;

EID: 0032891212     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023312     Document Type: Article

References (24)

1. Zakarija M, McKenzie JM, Hoffman WH: Prediction and therapy of intrauterine and late onset neonatal hyperthyrodism. J Clin Endocrinol Metab 1986;62:368-371.
2. Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E, Misrahi M: A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol 1996;81:2023-2026.
3. Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G: Brief Report: Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 1995;332:150-154.
4. Duprez L, Parma J, van Sande J, Allgeier A, Leclere J, Schwartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, Vassart G: Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genetics 1994;7: 396-401.
5. Holzapfel HP, Wonerow P, Petrykowski W, Henschen M, Scherbaum WA, Paschke R: Sporadic congenital hyperthyroidism due to a spontanous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 1997;82:3879-3884.
6. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, Rodd C: Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (Serine281 Isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 1997;100:1634-1639.
7. Tonacchera M, van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont JE, Vassart G: TSH receptor and disease. Clin Endocrinol 1996;44:621-633.
8. Tonacchera M, van Sande J, Cetani F, Swillens S, Schwartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J: Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 1996;81:547-554.
9. Vassart G, Georges M, Monsieur R, Brocas H, Lequarre AS, Christophe D: A sequence in M13 phage detects hypervariable minisatellites in human and animal DNA. Science 1987;235: 683-684.
10. Vitti P, Elisei R, Tonacchera L, Chiovato L, Mancusi F: Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. J Clin Endocrinol Metab 1993;76:499-503.
11. Andersen E, Hutchings B, Jansen J, Nyholm M: Heights and weights in Danish children. Ugeskrift Lager 1982;144:1760-1765.
12. Vassart G, Dumont JE: The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 1992;13:596-611.
13. Drexhage HA: Autoimmunity and thyroid growth: Where do we stand? Eur J Endocrinol 1996;135:39-45.
14. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Constagliola S, Rodien P, Dumont JE, Vassart G: Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alfa genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 1997;82:2695-2701.
15. Thomas J, Lecklere J, Hartemann P, Duhille J, Orgiazzi J, Petersen M, Janot C, Guedemnet JG: Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol 1982; 100:512-518.
16. Franklyn JA: Graves ophthalmopathy and the TSH receptor. Lancet 1993;342:318-319.
17. Stadlmayr W, Spitzweg C, Bichlmair AM, Heufelder AE: TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid 1997;7:3-12.
18. De Groot LJ, Larsen PRN, Hennemann G: The Thyroid and Its Disorders, ed 6. New York, Churchill-Livingstone, 1996.
19. Clark JD, Gelfand MJ, Elgazzar AH: Iodine-131 therapy of hyperthyroidism in pediatric patients. J Nucl Med 1995;36:442-445.
20. Lavard L, Ranløv I, Perrild H, Andersen O, Jacobsen BB: Incidence of juvenile thyrotoxicoses in Denmark 1982-88. Eur J Endocrinol 1994;130:565-568.
21. Perrild H, Jacobsen BB: Thyrotoxicosis in childhood. Eur J Endocrinol 1996;134:678-679.
22. Levy WJ, Schumacher P, Gupta M: Treatment of childhood Graves' disease. Cleveland Clin J Med 1988;55:373-382.
23. Perrild H, Gruters-Kieslich A, Feldt-Rasmussen U, Grant D, Martino E, Kayser L, DeLange F: Diagnosis and treatment of thyrotoxicosis in childhood. Eur J Endocrinol 1994;131:467-473.
24. Lippe B, Landaw EM, Kaplan SA: Hyperthyroidism in children treated with long-term medical therapy: Twenty-five percent remission every two years. J Clin Endocrinol. 1987; 64:1241-1245.